{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:16:14Z","timestamp":1791882974220,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The continuing rise of infections caused by multi-drug resistant bacteria has led to a renewed interest in bacteriophage therapy. Here we characterize phage vB_AbaM-KARL-1 with lytic activity against multi-drug resistant clinical isolates of\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    (AB). Besides genomic and phenotypic phage analysis, the objective of our study was to investigate the antibacterial outcome when the phage acts in concert with distinct antibiotics. KARL-1 belongs to the family of\n                    <jats:italic>Myoviridae<\/jats:italic>\n                    and is able to lyse 8 of 20 (40%) tested clinical isolates. Its double-stranded DNA genome consists of 166,560\u2009bp encoding for 253 open reading frames. Genome wide comparison suggests that KARL-1 is a novel species within the subfamily\n                    <jats:italic>Tevenvirinae<\/jats:italic>\n                    , sharing 77% nucleotide identity (coverage 58%) with phage ZZ1. The antibacterial efficacy at various multiplicities of infection (MOI) was monitored either alone or in combination with meropenem, ciprofloxacin, and colistin. A complete clearance of liquid cultures was achieved with KARL-1 at an MOI of 10\n                    <jats:sup>\u22121<\/jats:sup>\n                    and meropenem (&gt;128\u2009mg\/l). KARL-1 was still effective at an MOI of 10\n                    <jats:sup>\u22127<\/jats:sup>\n                    , but antibacterial activity was significantly augmented with meropenem. While ciprofloxacin did generally not support phage activity, the application of KARL-1 at an MOI of 10\n                    <jats:sup>\u22127<\/jats:sup>\n                    and therapeutic doses of colistin significantly elevated bacterial suppression. Hence, KARL-1 represents a novel candidate for use against multi-drug resistant AB and the therapeutic outcome may be positively influenced by the addition of traditional antibiotics.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-32344-y","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T09:43:40Z","timestamp":1536918220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii"],"prefix":"10.1038","volume":"8","author":[{"given":"Mathias","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wahida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Latz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kr\u00fcttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"H\u00e4fner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Miriam","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Horz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"32344_CR1","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan, R. et al. Antibiotic resistance\u2014the need for global solutions. Lancet Infect. Dis. 13, 1057\u20131098 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"32344_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tibtech.2010.08.001","volume":"28","author":"M Kutateladze","year":"2010","unstructured":"Kutateladze, M. & Adamia, R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 28, 591\u2013595 (2010).","journal-title":"Trends Biotechnol."},{"key":"32344_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1126\/science.aad6791","volume":"350","author":"R Young","year":"2015","unstructured":"Young, R. & Gill, J. J. Phage therapy redux\u2013What is to be done? Science 350, 1163\u20131164 (2015).","journal-title":"Science"},{"key":"32344_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tim.2015.01.006","volume":"23","author":"FL Nobrega","year":"2015","unstructured":"Nobrega, F. L., Costa, A. R., Kluskens, L. D. & Azeredo, J. Revisiting phage therapy: new applications for old resources. Trends Microbiol. 23, 185\u2013191 (2015).","journal-title":"Trends Microbiol."},{"key":"32344_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher, H. W. et al. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1\u201312 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"32344_CR6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice, L. B. Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE. J. Infect. Dis. 197, 1079\u20131081 (2008).","journal-title":"J. Infect. Dis."},{"key":"32344_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nrmicro1789","volume":"5","author":"L Dijkshoorn","year":"2007","unstructured":"Dijkshoorn, L., Nemec, A. & Seifert, H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5, 939\u2013951 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"32344_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","volume":"21","author":"AY Peleg","year":"2008","unstructured":"Peleg, A. Y., Seifert, H. & Paterson, D. L. Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21, 538\u2013582 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"32344_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhin.2007.02.016","volume":"66","author":"H Wisplinghoff","year":"2007","unstructured":"Wisplinghoff, H., Schmitt, R., W\u00f6hrmann, A., Stefanik, D. & Seifert, H. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. J. Hosp. Infect. 66, 174\u2013181 (2007).","journal-title":"J. Hosp. Infect."},{"key":"32344_CR10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1128\/jcm.35.6.1394-1397.1997","volume":"35","author":"C Wendt","year":"1997","unstructured":"Wendt, C., Dietze, B., Dietz, E. & R\u00fcden, H. Survival of Acinetobacter baumannii on dry surfaces. J. Clin. Microbiol. 35, 1394\u20131397 (1997).","journal-title":"J. Clin. Microbiol."},{"key":"32344_CR11","doi-asserted-by":"publisher","first-page":"e0172303","DOI":"10.1371\/journal.pone.0172303","volume":"12","author":"D Turner","year":"2017","unstructured":"Turner, D. et al. Characterisation and genome sequence of the lytic Acinetobacter baumannii bacteriophage vB_AbaS_Loki. PLOS ONE 12, e0172303 (2017).","journal-title":"PLOS ONE"},{"key":"32344_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jam.13134","volume":"121","author":"J Jeon","year":"2016","unstructured":"Jeon, J. et al. Characterization and complete genome sequence analysis of two Myoviral bacteriophages infecting clinical carbapenem-resistant Acinetobacter baumannii isolates. J. Appl. Microbiol. 121, 68\u201377 (2016).","journal-title":"J. Appl. Microbiol."},{"key":"32344_CR13","doi-asserted-by":"crossref","unstructured":"Cha, K. et al. Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in Vivo. Front. Microbiol. 9 (2018).","DOI":"10.3389\/fmicb.2018.00696"},{"key":"32344_CR14","doi-asserted-by":"crossref","unstructured":"Chen, L.-K. et al. Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains. Sci. Rep. 7 (2017).","DOI":"10.1038\/s41598-017-06688-w"},{"key":"32344_CR15","doi-asserted-by":"publisher","first-page":"e46537","DOI":"10.1371\/journal.pone.0046537","volume":"7","author":"G-H Shen","year":"2012","unstructured":"Shen, G.-H. et al. Isolation and Characterization of \u03d5km18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii. PLoS ONE 7, e46537 (2012).","journal-title":"PLoS ONE"},{"key":"32344_CR16","doi-asserted-by":"crossref","unstructured":"Hua, Y. et al. Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice. Front. Microbiol. 8 (2018).","DOI":"10.3389\/fmicb.2017.02659"},{"key":"32344_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.resmic.2010.03.007","volume":"161","author":"N-T Lin","year":"2010","unstructured":"Lin, N.-T., Chiou, P.-Y., Chang, K.-C., Chen, L.-K. & Lai, M.-J. Isolation and characterization of \u03d5AB2: a novel bacteriophage of Acinetobacter baumannii. Res. Microbiol. 161, 308\u2013314 (2010).","journal-title":"Res. Microbiol."},{"key":"32344_CR18","doi-asserted-by":"publisher","first-page":"e104853","DOI":"10.1371\/journal.pone.0104853","volume":"9","author":"M Merabishvili","year":"2014","unstructured":"Merabishvili, M. et al. Characterization of Newly Isolated Lytic Bacteriophages Active against Acinetobacter baumannii. PLoS ONE 9, e104853 (2014).","journal-title":"PLoS ONE"},{"key":"32344_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2180-14-181","volume":"14","author":"F Peng","year":"2014","unstructured":"Peng, F. et al. Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates. BMC Microbiol. 14, 181 (2014).","journal-title":"BMC Microbiol."},{"key":"32344_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2180-10-131","volume":"10","author":"H Yang","year":"2010","unstructured":"Yang, H., Liang, L., Lin, S. & Jia, S. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol. 10, 131 (2010).","journal-title":"BMC Microbiol."},{"key":"32344_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/v9070188","volume":"9","author":"A Popova","year":"2017","unstructured":"Popova, A. et al. Novel Fri1-like Viruses Infecting Acinetobacter baumannii\u2014vB_AbaP_AS11 and vB_AbaP_AS12\u2014Characterization, Comparative Genomic Analysis, and Host-Recognition Strategy. Viruses 9, 188 (2017).","journal-title":"Viruses"},{"key":"32344_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-2180-12-156","volume":"12","author":"J Jin","year":"2012","unstructured":"Jin, J. et al. Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol. 12, 156 (2012).","journal-title":"BMC Microbiol."},{"key":"32344_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/v10010005","volume":"10","author":"D Turner","year":"2017","unstructured":"Turner, D. et al. Comparative Analysis of 37 Acinetobacter Bacteriophages. Viruses 10, 5 (2017).","journal-title":"Viruses"},{"key":"32344_CR24","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/ps\/83.12.1944","volume":"83","author":"WE Huff","year":"2004","unstructured":"Huff, W. E., Huff, G. R., Rath, N. C., Balog, J. M. & Donoghue, A. M. Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers. Poult. Sci. 83, 1944\u20131947 (2004).","journal-title":"Poult. Sci."},{"key":"32344_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","volume":"65","author":"EM Ryan","year":"2012","unstructured":"Ryan, E. M., Alkawareek, M. Y., Donnelly, R. F. & Gilmore, B. F. Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol. Med. Microbiol. 65, 395\u2013398 (2012).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"32344_CR26","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1371\/journal.pone.0000799","volume":"2","author":"AM Comeau","year":"2007","unstructured":"Comeau, A. M., T\u00e9tart, F., Trojet, S. N., Pr\u00e8re, M.-F. & Krisch, H. M. Phage-Antibiotic Synergy (PAS): \u03b2-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth. PLoS ONE 2, e799 (2007).","journal-title":"PLoS ONE"},{"key":"32344_CR27","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1128\/AEM.02850-14","volume":"81","author":"F Kamal","year":"2015","unstructured":"Kamal, F. & Dennis, J. J. Burkholderia cepacia Complex Phage-Antibiotic Synergy (PAS): Antibiotics Stimulate Lytic Phage Activity. Appl. Environ. Microbiol. 81, 1132\u20131138 (2015).","journal-title":"Appl. Environ. Microbiol."},{"key":"32344_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1752-4571.2011.00236.x","volume":"5","author":"Q-G Zhang","year":"2012","unstructured":"Zhang, Q.-G. & Buckling, A. Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms: Phages limit bacterial antibiotic resistance. Evol. Appl. 5, 575\u2013582 (2012).","journal-title":"Evol. Appl."},{"key":"32344_CR29","doi-asserted-by":"publisher","first-page":"e56022","DOI":"10.1371\/journal.pone.0056022","volume":"8","author":"S Chhibber","year":"2013","unstructured":"Chhibber, S., Kaur, T. & Kaur, S. Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections. Plos One 8, e56022 (2013).","journal-title":"Plos One"},{"key":"32344_CR30","doi-asserted-by":"publisher","first-page":"e51017","DOI":"10.1371\/journal.pone.0051017","volume":"7","author":"AE Kirby","year":"2012","unstructured":"Kirby, A. E. Synergistic Action of Gentamicin and Bacteriophage in a Continuous Culture Population of Staphylococcus aureus. Plos one 7, e51017 (2012).","journal-title":"Plos one"},{"key":"32344_CR31","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/jac\/dkp360","volume":"64","author":"V Verma","year":"2009","unstructured":"Verma, V., Harjai, K. & Chhibber, S. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J. Antimicrob. Chemother. 64, 1212\u20131218 (2009).","journal-title":"J. Antimicrob. Chemother."},{"key":"32344_CR32","doi-asserted-by":"crossref","unstructured":"Chan, B. K. et al. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci. Rep. 6 (2016).","DOI":"10.1038\/srep26717"},{"key":"32344_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/emph\/eoy005","volume":"2018","author":"BK Chan","year":"2018","unstructured":"Chan, B. K. et al. Phage treatment aeruginosa. Evol. Med. Public Health 2018, 60\u201366 (2018).","journal-title":"Evol. Med. Public Health"},{"key":"32344_CR34","doi-asserted-by":"publisher","first-page":"e0168615","DOI":"10.1371\/journal.pone.0168615","volume":"12","author":"WN Chaudhry","year":"2017","unstructured":"Chaudhry, W. N. et al. Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms. Plos One 12, e0168615 (2017).","journal-title":"Plos One"},{"key":"32344_CR35","doi-asserted-by":"crossref","unstructured":"Danis-Wlodarczyk, K. et al. A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections. Sci. Rep. 6 (2016).","DOI":"10.1038\/srep28115"},{"key":"32344_CR36","doi-asserted-by":"publisher","unstructured":"Oechslin, F. et al. Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J. Infect. Dis. jiw632, https:\/\/doi.org\/10.1093\/infdis\/jiw632 (2016).","DOI":"10.1093\/infdis\/jiw632"},{"key":"32344_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/eva.12364","volume":"9","author":"C Torres-Barcel\u00f3","year":"2016","unstructured":"Torres-Barcel\u00f3, C., Franzon, B., Vasse, M. & Hochberg, M. E. Long-term effects of single and combined introductions of antibiotics and bacteriophages on populations of Pseudomonas aeruginosa. Evol. Appl. 9, 583\u2013595 (2016).","journal-title":"Evol. Appl."},{"key":"32344_CR38","doi-asserted-by":"publisher","first-page":"e106628","DOI":"10.1371\/journal.pone.0106628","volume":"9","author":"C Torres-Barcel\u00f3","year":"2014","unstructured":"Torres-Barcel\u00f3, C. et al. A Window of Opportunity to Control the Bacterial Pathogen Pseudomonas aeruginosa Combining Antibiotics and Phages. PLoS ONE 9, e106628 (2014).","journal-title":"PLoS ONE"},{"key":"32344_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.resmic.2012.08.008","volume":"164","author":"P Knezevic","year":"2013","unstructured":"Knezevic, P., Curcin, S., Aleksic, V., Petrusic, M. & Vlaski, L. Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa. Res. Microbiol. 164, 55\u201360 (2013).","journal-title":"Res. Microbiol."},{"key":"32344_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1089\/mdr.2006.12.164","volume":"12","author":"S Hagens","year":"2006","unstructured":"Hagens, S., Habel, A. & Bl\u00e4si, U. Augmentation of the Antimicrobial Efficacy of Antibiotics by Filamentous Phage. Microb. Drug Resist. 12, 164\u2013168 (2006).","journal-title":"Microb. Drug Resist."},{"key":"32344_CR41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/jobm.201600108","volume":"56","author":"S Latz","year":"2016","unstructured":"Latz, S. et al. Preliminary survey of local bacteriophages with lytic activity against multi-drug resistant bacteria: Bacteriophages against multi-drug resistant bacterial pathogens. J. Basic Microbiol. 56, 1117\u20131123 (2016).","journal-title":"J. Basic Microbiol."},{"key":"32344_CR42","doi-asserted-by":"publisher","first-page":"8107","DOI":"10.1128\/JVI.01340-15","volume":"89","author":"GF Hatfull","year":"2015","unstructured":"Hatfull, G. F. Dark Matter of the Biosphere: the Amazing World of Bacteriophage Diversity. J. Virol. 89, 8107\u20138110 (2015).","journal-title":"J. Virol."},{"key":"32344_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1006\/tpbi.2002.1590","volume":"61","author":"RW Hendrix","year":"2002","unstructured":"Hendrix, R. W. Bacteriophages: Evolution of the Majority. Theor. Popul. Biol. 61, 471\u2013480 (2002).","journal-title":"Theor. Popul. Biol."},{"key":"32344_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrmicro1750","volume":"5","author":"CA Suttle","year":"2007","unstructured":"Suttle, C. A. Marine viruses \u2014 major players in the global ecosystem. Nat. Rev. Microbiol. 5, 801\u2013812 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"32344_CR45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1743-422X-7-292","volume":"7","author":"VM Petrov","year":"2010","unstructured":"Petrov, V. M., Ratnayaka, S., Nolan, J. M., Miller, E. S. & Karam, J. D. Genomes of the T4-related bacteriophages as windows on microbial genome evolution. Virol. J. 7, 292 (2010).","journal-title":"Virol. J."},{"key":"32344_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jmb.2006.05.071","volume":"361","author":"VM Petrov","year":"2006","unstructured":"Petrov, V. M. et al. Plasticity of the Gene Functions for DNA Replication in the T4-like Phages. J. Mol. Biol. 361, 46\u201368 (2006).","journal-title":"J. Mol. Biol."},{"key":"32344_CR47","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1093\/bioinformatics\/btx440","volume":"33","author":"JP Meier-Kolthoff","year":"2017","unstructured":"Meier-Kolthoff, J. P. & G\u00f6ker, M. VICTOR: genome-based phylogeny and classification of prokaryotic viruses. Bioinformatics 33, 3396\u20133404 (2017).","journal-title":"Bioinformatics"},{"key":"32344_CR48","doi-asserted-by":"publisher","first-page":"e1002269","DOI":"10.1371\/journal.pcbi.1002269","volume":"7","author":"CJ Creevey","year":"2011","unstructured":"Creevey, C. J. et al. Identifying Single Copy Orthologs in Metazoa. PLoS Comput. Biol. 7, e1002269 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"32344_CR49","doi-asserted-by":"publisher","first-page":"e22099","DOI":"10.1371\/journal.pone.0022099","volume":"6","author":"CJ Creevey","year":"2011","unstructured":"Creevey, C. J., Doerks, T., Fitzpatrick, D. A., Raes, J. & Bork, P. Universally Distributed Single-Copy Genes Indicate a Constant Rate of Horizontal Transfer. PLoS ONE 6, e22099 (2011).","journal-title":"PLoS ONE"},{"key":"32344_CR50","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkv487","volume":"43","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Coleman-Derr, D., Chen, G. & Gu, Y. Q. OrthoVenn: a web server for genome wide comparison and annotation of orthologous clusters across multiple species. Nucleic Acids Res. 43, W78\u2013W84 (2015).","journal-title":"Nucleic Acids Res."},{"key":"32344_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1574-6968.2012.02573.x","volume":"332","author":"AV Popova","year":"2012","unstructured":"Popova, A. V., Zhilenkov, E. L., Myakinina, V. P., Krasilnikova, V. M. & Volozhantsev, N. V. Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii. FEMS Microbiol. Lett. 332, 40\u201346 (2012).","journal-title":"FEMS Microbiol. Lett."},{"key":"32344_CR52","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1128\/AEM.00526-16","volume":"82","author":"J Jeon","year":"2016","unstructured":"Jeon, J. et al. In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357. Appl. Environ. Microbiol. 82, 4200\u20134208 (2016).","journal-title":"Appl. Environ. Microbiol."},{"key":"32344_CR53","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1111\/1462-2920.13970","volume":"19","author":"H Oliveira","year":"2017","unstructured":"Oliveira, H. et al. Ability of phages to infect Acinetobacter calcoaceticus-Acinetobacter baumannii complex species through acquisition of different pectate lyase depolymerase domains: Specific genomic pattern variation of phages. Environ. Microbiol. 19, 5060\u20135077 (2017).","journal-title":"Environ. Microbiol."},{"key":"32344_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/v10040158","volume":"10","author":"I Huber","year":"2018","unstructured":"Huber, I. et al. 1st German Phage Symposium\u2014Conference Report. Viruses 10, 158 (2018).","journal-title":"Viruses"},{"key":"32344_CR55","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","volume":"24","author":"C Torres-Barcel\u00f3","year":"2016","unstructured":"Torres-Barcel\u00f3, C. & Hochberg, M. E. Evolutionary Rationale for Phages as Complements of Antibiotics. Trends Microbiol. 24, 249\u2013256 (2016).","journal-title":"Trends Microbiol."},{"key":"32344_CR56","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/jac\/dkp360","volume":"64","author":"V Verma","year":"2009","unstructured":"Verma, V., Harjai, K. & Chhibber, S. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J. Antimicrob. Chemother. 64, 1212\u20131218 (2009).","journal-title":"J. Antimicrob. Chemother."},{"key":"32344_CR57","doi-asserted-by":"publisher","first-page":"e01341","DOI":"10.1128\/mBio.01341-17","volume":"8","author":"RC Allen","year":"2017","unstructured":"Allen, R. C., Pfrunder-Cardozo, K. R., Meinel, D., Egli, A. & Hall, A. R. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical Escherichia coli Isolates. mBio 8, e01341\u201317 (2017).","journal-title":"mBio"},{"key":"32344_CR58","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1128\/AAC.01464-06","volume":"51","author":"F Perez","year":"2007","unstructured":"Perez, F. et al. Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 3471\u20133484 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"32344_CR59","first-page":"377","volume":"61","author":"K Drlica","year":"1997","unstructured":"Drlica, K. & Zhao, X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. MMBR 61, 377\u2013392 (1997).","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"key":"32344_CR60","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/281456a0","volume":"281","author":"LF Liu","year":"1979","unstructured":"Liu, L. F., Liu, C. C. & Alberts, B. M. T4 DNA topoisomerase: a new ATP-dependent enzyme essential for initiation of T4 bacteriophage DNA replication. Nature 281, 456\u2013461 (1979).","journal-title":"Nature"},{"key":"32344_CR61","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1185\/03007995.2015.1018989","volume":"31","author":"AZ Bialvaei","year":"2015","unstructured":"Bialvaei, A. Z. & Samadi Kafil, H. Colistin, mechanisms and prevalence of resistance. Curr. Med. Res. Opin. 31, 707\u2013721 (2015).","journal-title":"Curr. Med. Res. Opin."},{"key":"32344_CR62","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1751-7915.2008.00028.x","volume":"1","author":"K-P Kim","year":"2008","unstructured":"Kim, K.-P. et al. PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response. Microb. Biotechnol. 1, 247\u2013257 (2008).","journal-title":"Microb. Biotechnol."},{"key":"32344_CR63","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/jac\/dku173","volume":"69","author":"TM Viertel","year":"2014","unstructured":"Viertel, T. M., Ritter, K. & Horz, H.-P. Viruses versus bacteria\u2013novel approaches to phage therapy as a tool against multidrug-resistant pathogens. J. Antimicrob. Chemother. 69, 2326\u20132336 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"32344_CR64","doi-asserted-by":"publisher","first-page":"e1220348","DOI":"10.1080\/21597081.2016.1220348","volume":"6","author":"ST Abedon","year":"2016","unstructured":"Abedon, S. T. Phage therapy dosing: The problem(s) with multiplicity of infection (MOI). Bacteriophage 6, e1220348 (2016).","journal-title":"Bacteriophage"},{"key":"32344_CR65","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1128\/AAC.01582-09","volume":"54","author":"I Bilgrami","year":"2010","unstructured":"Bilgrami, I. et al. Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration. Antimicrob. Agents Chemother. 54, 2974\u20132978 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"32344_CR66","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000074527","volume":"49","author":"WA Krueger","year":"2003","unstructured":"Krueger, W. A. et al. Correlation of Meropenem Plasma Levels with Pharmacodynamic Requirements in Critically Ill Patients Receiving Continuous Veno-Venous Hemofiltration. Chemotherapy 49, 280\u2013286 (2003).","journal-title":"Chemotherapy"},{"key":"32344_CR67","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1128\/AAC.46.12.3724-3730.2002","volume":"46","author":"M Brunner","year":"2002","unstructured":"Brunner, M. et al. Target Site Concentrations of Ciprofloxacin after Single Intravenous and Oral Doses. Antimicrob. Agents Chemother. 46, 3724\u20133730 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"32344_CR68","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1128\/AAC.06426-11","volume":"56","author":"AF Mohamed","year":"2012","unstructured":"Mohamed, A. F. et al. Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill. Antimicrob. Agents Chemother. 56, 4241\u20134249 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"32344_CR69","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1128\/AAC.00517-16","volume":"60","author":"L Dortet","year":"2016","unstructured":"Dortet, L., Fusaro, M. & Naas, T. Improvement of the Xpert Carba-R Kit for the Detection of Carbapenemase-Producing Enterobacteriaceae. Antimicrob. Agents Chemother. 60, 3832\u20133837 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"32344_CR70","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1099\/jmm.0.45611-0","volume":"53","author":"MW Syrmis","year":"2004","unstructured":"Syrmis, M. W. Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. J. Med. Microbiol. 53, 1089\u20131096 (2004).","journal-title":"J. Med. Microbiol."},{"key":"32344_CR71","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1093\/nar\/19.24.6823","volume":"19","author":"J Versalovic","year":"1991","unstructured":"Versalovic, J., Koeuth, T. & Lupski, J. R. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19, 6823\u20136831 (1991).","journal-title":"Nucleic Acids Res."},{"key":"32344_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/v9110315","volume":"9","author":"S Latz","year":"2017","unstructured":"Latz, S. et al. Differential Effect of Newly Isolated Phages Belonging to PB1-Like, phiKZ-Like and LUZ24-Like Viruses against Multi-Drug Resistant Pseudomonas aeruginosa under Varying Growth Conditions. Viruses 9, 315 (2017).","journal-title":"Viruses"},{"key":"32344_CR73","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/cmb.2012.0021","volume":"19","author":"A Bankevich","year":"2012","unstructured":"Bankevich, A. et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing. J. Comput. Biol. 19, 455\u2013477 (2012).","journal-title":"J. Comput. Biol."},{"key":"32344_CR74","doi-asserted-by":"crossref","unstructured":"Alikhan, N.-F., Petty, N. K., Ben Zakour, N. L. & Beatson, S. A. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12, (2011).","DOI":"10.1186\/1471-2164-12-402"},{"key":"32344_CR75","first-page":"2607","volume":"29","author":"J Besemer","year":"2001","unstructured":"Besemer, J., Lomsadze, A. & Borodovsky, M. GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res. 29, 2607\u20132618 (2001).","journal-title":"Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res."},{"key":"32344_CR76","doi-asserted-by":"publisher","first-page":"W16","DOI":"10.1093\/nar\/gkw387","volume":"44","author":"D Arndt","year":"2016","unstructured":"Arndt, D. et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res. 44, W16\u2013W21 (2016).","journal-title":"Nucleic Acids Res."},{"key":"32344_CR77","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/nar\/25.5.0955","volume":"25","author":"TM Lowe","year":"1997","unstructured":"Lowe, T. M. & Eddy, S. R. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 25, 955\u2013964 (1997).","journal-title":"Nucleic Acids Res."},{"key":"32344_CR78","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1101\/gr.1224503","volume":"13","author":"L Li","year":"2003","unstructured":"Li, L. OrthoMCL: Identification of Ortholog Groups for Eukaryotic Genomes. Genome Res. 13, 2178\u20132189 (2003).","journal-title":"Genome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32344-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32344-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32344-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:46:28Z","timestamp":1671597988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32344-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["32344"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-32344-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]},"assertion":[{"value":"29 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14140"}}